Merck & Co.

BioNTech and Weizmann Institute to collaborate at company’s new mRNA centre in Israel

Professor Ugur Sahin, chief executive officer and co-founder of BioNTech, said: “We are pleased to establish mRNA research laboratories on the campus of the Weizmann Institute of Science.

Eli Lilly signs agreement worth up to $600m for Confo Therapeutics' non-opioid pain candidate

Confo has retained a co-investment option, which would allow the company to participate in the funding of future development programmes after clinical proof-of-concept for additional royalties.

Moderna/Merck’s skin cancer therapy given FDA breakthrough therapy designation

Moderna and Merck – known as MSD outside the US and Canada – have said their investigational personalised mRNA cancer vaccine, in combination with Merck’s Keytruda, has been given breakthrough therapy designation ... Dr Eric Rubin, senior vice

European Commission grants AstraZeneca three new approvals

of acid-reducing agents for conditions such as gastro-oesophageal reflux, saying: “The tablet formulation allows for co-administration with these drugs, allowing more patients with CLL to assume Calquence.”.

In uncertain times, plan for the actions you may never take

Defining critical growth drivers. Using ‘practical’ AGILE techniques:. To co-create cross-functional plans, with a laser focus on the critical decisions that need to be made, driven by deep external

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]